Europe Telemedicine Market Analysis and Opportunities by 2028

The telemedicine market in Europe is expected to grow from US$ 18,737.90 million in 2021 to US$ 60,872.19 million by 2028; it is estimated to grow at a CAGR of 18.3% from 2021 to 2028.

France, Germany, Italy, Spain, and UK are major economies in Europe. Significant rise in chronic and lifestyle-associated diseases is the major factor driving the growth of the Europe telemedicine market. The rising incidence of chronic diseases is a Europe concern, and these diseases cause extra financial burden on healthcare sectors. Telehomecare is a pioneering way to provide care, monitor patients, and transmit information by using latest telecommunication technologies. Monitoring allows early-stage identification of disease, thus preventing chronic disease conditions. Telehome systems can be used to track and support patients with a variety of respiratory and chronic conditions that can be treated without the need of hospital visits. Furthermore, telehome services could also help reduce communications in person and lower the spread of communicable diseases. The implementation of telehome services also benefits patients economically and lowers the burden on physicians. According to the World Health Organization (WHO), chronic diseases are the leading causes of death worldwide, accounting for 60% of total deaths. Among all chronic diseases, cardiovascular diseases (CVDs) are the leading cause of deaths. The prevalence of chronic diseases such as cancer, CVDs, stroke, respiratory diseases, and diabetes is increasing due to alterations in lifestyle and lack of access to preventive care. The causes of chronic diseases may vary from genetic disposition to environmental factors and oxidative stress. The rising incidence of these chronic diseases is propelling the demand and adoption of telemedicine platforms.  

The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Spain, Italy, Germany, France, and the UK are a few most-affected European countries. On March 11, 2020, the COVID-19 outbreak was declared a pandemic by the World Health Organization, radically changing the way medicine is practiced. In the span of a few weeks, as quarantining and social distancing became the norm, in-person medical visits plummeted, suddenly thrusting telemedicine from the wings of medical care to center stage. Moreover, according to a report of UK August 2020, Scotland is again making progress on facing the COVID-19 outbreak. A collaboration between the Scottish Intercollegiate Guidelines Network (SIGN) and the Digital Health and Care Institute (DHI) has resulted in a decision support tool for predicting severe diseases. It forms part of Scotland’s COVID-19 assessment in primary care. Telemedicine experienced a huge surge in the adoption over the past few months during the pandemic. During lockdown, it has become the 'new normal' way of accessing healthcare. 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe telemedicine market. The Europe telemedicine market is expected to grow at a good CAGR during the forecast period.

Europe Telemedicine Market Segmentation

Europe Telemedicine Market – By Type

• Telehospital
• Telehome

Europe Telemedicine Market – By Product and Services

• Software and Hardware
• Tele-Consulting
• Tele-Monitoring
• Tele-Education/Training

Europe Telemedicine Market – By Specialty

• Cardiology
• Gynecology
• Neurology
• Orthopedics
• Dermatology
• Mental Health
• Others

Europe Telemedicine Market – By Delivery Mode

• Mobile
• Call Centres
• Web

Europe Telemedicine Market, by Country

• France
• Germany
• Italy
• Spain
• U.K.
• Rest of Europe

Europe Telemedicine Market - Companies Mentioned

• Allscripts Healthcare Solutions, Inc.
• Cerner Corporation
• Cisco Systems, Inc.
• Honeywell International, Inc.
• Insight
• Koninklijke Philips N.V
• McKesson Corporation
• Teladoc Health

Europe Telemedicine Report Scope